🌟 Discover the Future of Oncology at SLCO Annual Academic Sessions 2023! 🌟 📅 October 13th - 15th, 2023. 🏨 Hotel Galadari, Colombo. Visit slco.lk for registration! #SLCOnc2023 #OncologyConference

This is absolutely brilliant. Not only is the data compelling, Shankar Siva, but it is presented in a manner that I feel may be quite conducive to sharing with my patients for discussion (thoughts, Laura Esfeller @DebMaskens Dena Battle Bryan Lewis?). Your talk at #ASTRO23

October is #BreastCancer #Awareness month. The commonest cancer among women in #SriLanka it is eminently curable if detected early. SL Cancer Research Group @indira_trust #lka

Twice daily radiotherapy to 54Gy BID ⬆️⬆️ OS and PFS in small cell #lungcancer as compared to 45Gy BID. compared to CONVERT and RTOG, higher once daily RT did not ⬆️ OS. #lcsm - abstract ➡️ shorturl.at/huDJ2 - time to change?

I've used this widely in my practice due to resource constraints with excellent results.. #hypofractionation #headandneckcancer The Sri Lanka College of Oncologists @slcancer Vimukthini Peiris

Honoured to have been given the #opportunity be a part of the 4th batch of #LeadershipDevelopment program of FARO_Asia. Thank you #FARO and The Sri Lanka College of Oncologists!

"No matter what obstacles we encounter, we owe it to our patients not to allow the high standards we have upheld thus far, to diminish. Therefore, excellence should remain our ultimate goal in all that we do" Inspiring words by #SLCO president Prasad Abeysinghe sundaytimes.lk/231029/news/im…

📌Watch our eminent consultant oncologist Nuradh Joseph speak on #breastcancer 🇱🇰 #BreastCancerAwareness Ada Derana fb.watch/o63KIjHROj/

Testicular cancer in 2023- a good review acsjournals.onlinelibrary.wiley.com/doi/full/10.33……

COLOMBO....🇱🇰 📸 Thilina Kaluthotage

Wishing you a year filled with strength, resilience, and healing. Happy New Year! #NewYear #2024NewYear

In Sri Lanka there's this massive column of rock nearly 200 m high that hosts a 1600-year-old fortress on its top [read more: buff.ly/48g9IVX]

✨Join us at NCISL where a star studded cast will discuss the latest advancements in #Oncology organised by the The College of Surgeons of Sri Lanka and The Sri Lanka College of Oncologists in collaboration with Tata Memorial Hospital Centre #India✨ 24th January 2024. Prasad Abeysinghe dr pawan rane Shailesh V. Shrikhande

1/N Finally out!! -- 30Gy for HPV+OPC in Journal of Clinical Oncology – work by the Memorial Sloan Kettering Cancer Center Head and Neck team, led by Nancy Lee, Eric Sherman, and myself on using hypoxia imaging response to cut treatment 60% (70->30Gy)! #radonc #hncsm ascopubs.org/doi/10.1200/JC…

TiP: EA8211-SOAR: Non-inferiority phase 3 trial of SABR vs systemic therapy for metachronous (pre-treated) oligometastatic RCC (2-5 mets, IMDC fav-int risk) 🔷SABR arm: Systemic therapy only following progression 🔷Co-primary: OS & Gr≥3 toxicity 🔷Secondary: QoL, PFS,

The standard of care for stage III NSCLC changes once again; Say goodbye to Durvalumab for patients with mEGFR (ex19del & L858R). #radonc astrazeneca.com/media-centre/p…

MONARCH 3: Final overall survival results 🔍mFU: 8.1 years (OS: secondary endpoint) mOS➡️66.8 vs 53.7 mo (HR:0.8, p:0.06) 💥The absolute difference was 13.1 months but did not reach statistical significance Annals of Oncology OncoAlert annalsofoncology.org/article/S0923-…

WOW! HPV ctDNA detection at 3 months after dCRT for anal canal cancer associated with 100% risk of recurrence! 8% with HPV ctDNA negative #ASCO24

Have u ever seen curves as wide as this for any drug recently? Lorlatinib for metastatic ALK positive NSCLC. Great results 👏. It works With reduced dose also. Let's hope it becomes more accessible. @asco #asco24 OncoAlert Oncology Brothers LARVOL Alfredo Addeo MD H. Jack West, MD, FASCO

21st #AnnualAcedemicSessions of The Sri Lanka College of Oncologists kicks off to an auspicious start! Prabani sidath wijesekera